Lexicon Pharma (LXRX) reported Q1 Revenue
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.17 --0%
EPS Growth %: -600.0%
Financial Fact:
Collaborative research: 27.69M
Today's EPS Names:
CCEL, FNGR, FAST, More
EPS Growth %: -600.0%
Financial Fact:
Collaborative research: 27.69M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q1 Revenue for the quarter came in at $21.1 million versus the consensus estimate of $9.78 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue
- Bernstein SocGen Group Starts Asymchem Laboratories Tianjin Co Ltd (002821:CH) at Outperform
- BP cuts Q2 2026 production outlook, net debt expected to fall
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
